A team at Emory University Health Sciences Centre in America conducted a study of 100 patients with blunt TBI, which typically occurs in falls or in car and motorcycle crashes. About 13 percent of TBI patients who received intravenous progesterone died within 30 days, compared to about 30 percent of patients who received a placebo. The findings were published online in the October issue of the Annals of Emergency Medicine.
Back